Molecular Mechanisms Underlying The Positive Associations Between Male Gender And Leptin With Barretts Oesophagus
Funder
National Health and Medical Research Council
Funding Amount
$387,489.00
Summary
Barrett's oesophagus is a disease of the gullet that can lead to the development of oesophageal cancer, which has a very poor outcome. We have shown that the risk of Barrett's oesophagus is greatest in obese males with a high blood level of leptin, a hormone made in fat tissue. The aim of this study is to examine how leptin causes this increased cancer risk, so that new treatments or tests for Barrett's and oesophageal cancer can be developed.
Biomarkers In Barrett's Oesophagus And Oesophageal Adenocarcinoma
Funder
National Health and Medical Research Council
Funding Amount
$67,690.00
Summary
Barrett’s oesophagus (BO) is a condition in which the normal lining of the lower oesophagus is replaced with intestine-like tissue as a response to long-standing acid reflux. BO can progress to oesophageal adenocarcinoma (OAC), an aggressive cancer with poor 5-year survival rates of ~15%. This project aims at detecting genetic and molecular changes that occur in both BO and OAC and which may help predict the risk of progression as well as survival for patients affected by this disease entity.
Blood Serum MicroRNA Biomarkers For Oesophageal Cancer
Funder
National Health and Medical Research Council
Funding Amount
$495,433.00
Summary
Oesophageal adenocarcinoma (OAC) is the 6th commonest cause of cancer deaths in the Western World, and is increasing in incidence. In Australia most patients present late and require risky treatments with a low cure rate. There is a big difference in survival between individuals presenting early vs. late. Better methods to detect cancer early or detect pre-cancer will improve outcomes. Our research will develop a blood test for identifying individuals with early OAC to allow earlier treatment.
Endoscopic Removal Of Lesions In The Gastrointestinal Tract
Funder
National Health and Medical Research Council
Funding Amount
$71,855.00
Summary
Barrett's oesophagus and flat colonic polyps are premalignant lesions with potential for progression to oesophageal and colorectal cancer, respectively. These cancers make up a signifiant portion of the burden of cancer disease in Australia. This research aims to improve outcomes of patients with Barrett's oesophagus and flat polyps by establishing the most appropriate treatment approach to Barrett's oesophagus, identifying risk factors that cause disease progression and by novel ways of enhanci ....Barrett's oesophagus and flat colonic polyps are premalignant lesions with potential for progression to oesophageal and colorectal cancer, respectively. These cancers make up a signifiant portion of the burden of cancer disease in Australia. This research aims to improve outcomes of patients with Barrett's oesophagus and flat polyps by establishing the most appropriate treatment approach to Barrett's oesophagus, identifying risk factors that cause disease progression and by novel ways of enhancing the technique of removal of polyps.Read moreRead less
PROBE-NET: The Progression Of Barrett's Esophagus To Cancer Network
Funder
National Health and Medical Research Council
Funding Amount
$2,465,844.00
Summary
This application brings together the seven major research teams in Australia with expertise in oesophageal neoplasia to form a multi-state, multi-disciplinary Centre for Research Excellence. All of the nodes have worked together collaboratively for the past 4 years, pooling their expertise in surgery, gastroenterology, endoscopy, epidemiology, biostatistics, basic science, health policy and translational research. Our vision is to develop evidence-based strategies for reducing the burden of oeso ....This application brings together the seven major research teams in Australia with expertise in oesophageal neoplasia to form a multi-state, multi-disciplinary Centre for Research Excellence. All of the nodes have worked together collaboratively for the past 4 years, pooling their expertise in surgery, gastroenterology, endoscopy, epidemiology, biostatistics, basic science, health policy and translational research. Our vision is to develop evidence-based strategies for reducing the burden of oesophageal neoplasia.Read moreRead less
Professor Whiteman is a medical epidemiologist with interests in the causes, prevention and treatment of cancer. His fellowship will be directed towards research focussing on methods for controlling cancers of the skin and oesophagus.
Endoscopic Diagnosis And Therapy: The Frontier Of Minimally Invasive Patient Care.
Funder
National Health and Medical Research Council
Funding Amount
$344,644.00
Summary
Minimally invasive diagnosis and treatment is a rapidly developing field, and has potential to significantly improve patient management and health care utilization. This research will apply endoscopic innovations to diagnose and treat early oesophageal and pancreatic cancer, with the aim to improve survival and quality of life. The research will also develop capacity to treat oesophageal motility disorders with minimally invasive endoscopic resection techniques.